See more : Unicharm Corporation (UNCHF) Income Statement Analysis – Financial Results
Complete financial analysis of Cordlife Group Limited (CLIFF) income statement, including revenue, profit margins, EPS and key performance metrics. Get detailed insights into the financial performance of Cordlife Group Limited, a leading company in the Medical – Diagnostics & Research industry within the Healthcare sector.
- Lushang Life Services Co., Ltd. (2376.HK) Income Statement Analysis – Financial Results
- Shidax Corporation (4837.T) Income Statement Analysis – Financial Results
- Promate Solutions Corporation (6577.TWO) Income Statement Analysis – Financial Results
- GKB Ophthalmics Limited (GKB.BO) Income Statement Analysis – Financial Results
- Magadh Sugar & Energy Limited (MAGADSUGAR.NS) Income Statement Analysis – Financial Results
Cordlife Group Limited (CLIFF)
About Cordlife Group Limited
Cordlife Group Limited, an investment holding company, provides cord blood banking services in Singapore, Hong Kong, India, Malaysia, the Philippines, and internationally. The company operates through two segments, Banking and Diagnostics. It provides cord blood, cord lining, and cord tissue banking services comprising processing and storage of stem cells; and non-invasive prenatal testing, paediatric vision screening, newborn metabolic screening, and newborn genetic screening services. The company also offers preimplantation genetic screening, endometrial receptivity test, paediatric allergen test, and genetic talent test services, as well as moms up, a mobile app for pregnancy and parenting resources. In addition, it provides management, marketing, and property investment services. Cordlife Group Limited was incorporated in 2001 and is headquartered in Singapore.
| Metric | 2023 | 2022 | 2021 | 2020 | 2019 | 2018 | 2017 | 2016 | 2015 | 2014 | 2013 | 2012 | 2011 | 2010 |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Revenue | 55.73M | 55.16M | 42.00M | 44.63M | 45.80M | 60.33M | 68.31M | 59.96M | 59.63M | 42.76M | 49.09M | 34.70M | 30.28M | 25.67M |
| Cost of Revenue | 18.43M | 17.97M | 13.43M | 15.22M | 17.19M | 23.93M | 22.55M | 22.43M | 20.90M | 13.21M | 14.23M | 9.37M | 8.74M | 7.41M |
| Gross Profit | 37.31M | 37.19M | 28.57M | 29.41M | 28.61M | 36.40M | 45.76M | 37.54M | 38.73M | 29.56M | 34.86M | 25.33M | 21.53M | 18.26M |
| Gross Profit Ratio | 66.94% | 67.43% | 68.02% | 65.91% | 62.47% | 60.34% | 66.99% | 62.60% | 64.95% | 69.11% | 71.01% | 72.99% | 71.12% | 71.14% |
| Research & Development | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 | 0.00 |
| General & Administrative | 18.97M | 18.25M | 18.45M | 19.46M | 21.21M | 16.72M | 22.51M | 19.53M | 19.77M | 17.25M | 14.97M | 10.20M | 9.16M | 5.54M |
| Selling & Marketing | 19.33M | 18.04M | 17.54M | 18.43M | 21.92M | 15.75M | 20.97M | 19.62M | 19.01M | 17.66M | 12.16M | 7.80M | 6.91M | 5.88M |
| SG&A | 38.30M | 36.29M | 25.98M | 27.74M | 31.35M | 42.67M | 43.48M | 37.81M | 37.74M | 25.76M | 27.12M | 18.00M | 16.07M | 11.41M |
| Other Expenses | -3.74M | 292.00K | 577.00K | 501.00K | 413.00K | 0.00 | 944.00K | 131.00K | -1.79M | 357.00K | 338.00K | 28.00K | 75.00K | 1.68M |
| Operating Expenses | 34.56M | 35.97M | 25.98M | 27.74M | 31.35M | 42.67M | 42.53M | 37.68M | 37.74M | 25.76M | 26.19M | 18.00M | 16.00M | 11.05M |
| Cost & Expenses | 52.99M | 53.93M | 39.41M | 42.96M | 48.54M | 66.60M | 65.08M | 60.11M | 58.63M | 38.97M | 40.42M | 27.37M | 24.74M | 18.46M |
| Interest Income | 3.42M | 2.69M | 1.68M | 1.69M | 7.71M | 6.70M | 1.25M | 1.86M | 5.35M | 7.04M | 288.00K | 492.00K | 157.00K | 1.09M |
| Interest Expense | 268.00K | 152.00K | 148.22K | 258.01K | 231.29K | 0.00 | 248.00K | 2.01M | 5.59M | 4.78M | 217.00K | 46.00K | 2.00K | 43.00K |
| Depreciation & Amortization | 4.03M | 3.68M | 3.57M | 4.14M | 4.28M | 3.00M | 2.81M | 3.13M | 2.52M | 1.25M | 1.51M | 765.00K | 681.00K | 588.00K |
| EBITDA | 8.56M | 9.34M | 10.78M | 12.04M | 12.72M | -3.27M | 7.38M | 3.21M | 3.51M | 5.05M | 8.57M | 12.64M | 8.46M | 10.57M |
| EBITDA Ratio | 15.35% | 16.57% | 12.47% | 10.77% | 0.96% | -5.41% | 10.81% | 4.98% | 5.88% | 11.81% | 17.45% | 36.43% | 27.95% | 41.15% |
| Operating Income | 2.74M | 4.25M | 2.59M | 1.67M | -2.74M | -6.26M | 4.23M | -143.00K | 994.00K | 3.80M | 9.08M | 10.09M | 4.03M | 7.21M |
| Operating Income Ratio | 4.92% | 7.70% | 6.16% | 3.75% | -5.99% | -10.38% | 6.19% | -0.24% | 1.67% | 8.88% | 18.50% | 29.07% | 13.32% | 28.09% |
| Total Other Income/Expenses | 1.52M | 1.26M | 611.00K | 546.00K | 619.00K | 9.93M | 95.00K | -1.78M | 10.41M | 27.16M | 22.77M | 7.00M | 3.75M | 2.72M |
| Income Before Tax | 4.26M | 5.50M | 4.87M | 5.44M | 6.04M | 3.66M | 4.33M | -1.92M | 13.34M | 24.71M | 31.85M | 14.56M | 7.78M | 9.93M |
| Income Before Tax Ratio | 7.64% | 9.98% | 11.61% | 12.18% | 13.19% | 6.07% | 6.33% | -3.20% | 22.37% | 57.77% | 64.89% | 41.95% | 25.70% | 38.69% |
| Income Tax Expense | 692.00K | 617.00K | 647.72K | 757.39K | 1.24M | 1.88M | 1.14M | 675.00K | 760.00K | 848.87K | 1.47M | 1.08M | 854.00K | 1.46M |
| Net Income | 3.52M | 4.89M | 4.55M | 4.95M | 4.81M | 1.78M | 3.27M | -2.57M | 12.33M | 24.11M | 30.52M | 13.48M | 6.93M | 8.48M |
| Net Income Ratio | 6.32% | 8.86% | 10.83% | 11.10% | 10.51% | 2.94% | 4.79% | -4.29% | 20.68% | 56.37% | 62.18% | 38.86% | 22.88% | 33.02% |
| EPS | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | -0.01 | 0.05 | 0.09 | 0.12 | 0.06 | 0.04 | 0.06 |
| EPS Diluted | 0.01 | 0.02 | 0.02 | 0.02 | 0.02 | 0.01 | 0.01 | -0.01 | 0.05 | 0.09 | 0.12 | 0.06 | 0.04 | 0.06 |
| Weighted Avg Shares Out | 257.15M | 255.75M | 255.10M | 254.31M | 253.59M | 253.02M | 253.03M | 259.37M | 259.33M | 260.04M | 256.52M | 232.57M | 171.73M | 150.89M |
| Weighted Avg Shares Out (Dil) | 256.29M | 256.23M | 256.23M | 256.37M | 254.63M | 254.29M | 254.50M | 259.37M | 259.77M | 260.34M | 256.59M | 232.57M | 171.73M | 150.89M |
Source: https://incomestatements.info
Category: Stock Reports